Evolut Low Risk Trial

The University of Michigan Frankel Cardiovascular Center is one of 80 sites in the United States participating in an important study evaluating the CoreValve® Evolut® R system for the treatment of severe aortic stenosis (AS) in a new patient population. 

Click here for more information.